Spinal Cord Injury Stem Cell Therapy in Istanbul, Turkey

An intrathecal procedure involves procedure-room time, anesthesia support and an observation period that an infusion does not, and accessible transport and accommodation add real cost on top. Our patient coordination team quotes those separately from the treatment itself and states what a further session would involve before you decide.

Restoring lost movement is not something we claim, and anyone who does should be treated with caution. Our team sets goals in areas where change is measurable and meaningful - spasticity, neuropathic pain, trunk stability, transfers, comfort during daily care - and reviews them honestly at agreed points.

Our case reviews are in the chronic phase, after surgical care, stabilisation and the main rehabilitation program. At that stage our medical team looks at completeness, current function, complication history and your goals rather than at the calendar, and says clearly when travel would not be worth the burden.

Accessibility is planned before the medical schedule is fixed: accessible transport, room requirements, transfer support, pressure-relief timing during long days, and catheter and bowel program scheduling. Tell our patient coordination team what your routine requires and it is built into the plan rather than improvised on arrival.

Yes. Our regenerative medicine program works with mesenchymal stromal cells (MSCs) grown from Wharton's jelly, the gelatinous tissue inside the umbilical cord. It is donated after a healthy birth with written maternal consent, from tissue that would otherwise be discarded, so nothing is taken from mother or baby and none of the ethical questions attached to embryonic sources arise. Because these cells expand readily in culture, a batch is characterised and release-tested before it reaches anyone. Your written plan names the material, how it is prepared, the dose, the route of administration and the schedule, and our medical team explains why each of those was chosen for your case.

Wharton's jelly is a young, perinatal tissue rather than an adult one, so the starting material does not carry the age or the health history of the person being treated, and nothing has to be harvested from you on the day. These cells also have a low-immunogenicity profile, which is why this source is studied for use between unrelated people. Most of all, they are strong secretors: the signalling molecules MSCs release are the mechanism most current research centres on, and that is what a plan is built around.

The length of stay follows your plan: the route of administration, the number of sessions, the monitoring after each one, and any mobility or assistance you need. Our patient coordination team confirms appointment dates, daily timings and the expected length of the visit in writing before you book flights.

No medical procedure is free of risk. Our medical team screens for infection, bleeding risk, medication interactions and other contraindications before treatment, explains the risks specific to the route used in your plan, and monitors you during administration and afterwards. If something makes treatment unsafe for you, we say so instead of proceeding.

Goals are set with you and described as aims, not results. Regenerative medicine treatments are planned individually, responses vary between patients and no clinical outcome can be guaranteed. Your plan states what will be measured, when it will be reviewed, and how treatment sits alongside the care you already receive.

Send your confirmed diagnosis, recent reports and imaging, your current medication list, previous procedures and the goals that matter to you. Our medical team reviews them remotely and comes back with an assessment of whether treatment in Istanbul is appropriate for your case, and what the next step would be.